Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Xiaonan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2168-0319; OpenAlex author ID A5130662382. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. Lipid Nanoparticle-Based αHTRA1 mRNA Improves Pancreatic Ductal Adenocarcinoma Redox Microenvironment by Suppressing HTRA1/HIF-1 Signaling. Co-author DOI 10.1021/acs.bioconjchem.6c00013↗
  2. Peptides in the Diagnosis and Treatment of Pancreatic Cancer and Other Pancreatic Diseases from Basic Research to Clinical Translation. First author DOI 10.2147/dddt.s610190↗
  3. Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives. Co-author DOI 10.3389/fimmu.2026.1785625↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xufeng Tao · 3 shared papers, 2026 · strength 0.96
  2. Deshi Dong · 3 shared papers, 2026 · strength 0.96
  3. Guangshuo Gan · 2 shared papers, 2026 · strength 0.65
  4. Xinya Zhao · 1 shared paper, 2026 · strength 0.32
  5. Fangyue Guo · 1 shared paper, 2026 · strength 0.32
  6. Xu Yao · 1 shared paper, 2026 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.